MLL-AF9 induced pre-B-ALL;MLL-ENL induced B-ALL;High penetrance and short latency with a median of 7 weeks and lineage switching similar to MLL-rearranged patients at relapse. This evidence concerns the gene KMT2A and acute lymphoblastic leukemia.